Ofev loe?

Question

Ofev loe?

Accepted Answer

I’m not entirely sure what “loe” refers to in this context—perhaps it’s a typo or an abbreviation you’re using. If you’re asking about Ofev (ofatumumab), here’s a quick overview:

Topic	Details
Brand name	Ofev
Generic	Ofatumumab
Indications	• Relapsing‑remitting multiple sclerosis (RRMS) in adults • Chronic lymphocytic leukemia (CLL) in adults and children (≥12 y) with CD20‑positive B‑cell disease
Administration	Subcutaneous injection: 300 mg on day 1, 300 mg on day 8, then 300 mg every 8 weeks thereafter (for MS); for CLL, the dosing schedule is more complex and is usually managed in oncology settings.
Common side effects	Injection‑site reactions, upper respiratory infections, headache, fatigue, diarrhea, rash
Serious risks	Infusion‑related reactions (rare with subcutaneous), serious infections, hypersensitivity, rare cases of progressive multifocal leukoencephalopathy (PML) in other anti‑CD20 therapies (none reported for Ofev as of the latest data), potential for immunogenicity
Monitoring	Baseline and periodic CBC, liver function tests, screening for hepatitis B and other infections if indicated, monitoring for signs of infection or allergic reactions
Contraindications	Known hypersensitivity to ofatumumab or any component; active uncontrolled infection

If you meant something else by “loe” (e.g., a specific dosage form, a particular side effect, a regulatory term, or a language abbreviation), or if you have a specific question—like dosing details for a certain patient profile, insurance coverage, or interactions—just let me know!

Ask Questions, Get Industry Insights … Instantly

Recent Questions

Ofev loe?